[Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition].

{"article_title":"[Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition].","author":"Joo MK, Park CH, Kim JS, Park JM, Ahn JY, Lee BE, Lee JH, Yang HJ, Cho YK, Bang CS, Kim BJ, Jung HK, Kim BW, Lee YC","journal_title":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","issn":"2233-6869","isbn":"","publication_date":"2021 Nov 15","volume":"76","issue":"3","first_page":"108","page_count":"","accession_number":"32969360","doi":"10.4166\/kjg.2020.76.3.108","publisher":"Korean Society of Gastroenterology","doctype":"Journal Article","subjects":"Peptic Ulcer prevention & control; Anti-Inflammatory Agents adverse effects; Anti-Inflammatory Agents therapeutic use; Anticoagulants adverse effects; Anticoagulants therapeutic use; Cyclooxygenase 2 Inhibitors therapeutic use; Endoscopy, Gastrointestinal; Helicobacter Infections diagnosis; Helicobacter Infections drug therapy; Hemorrhage complications; Hemorrhage therapy; Humans; Peptic Ulcer diagnosis; Peptic Ulcer etiology; Platelet Aggregation Inhibitors adverse effects; Platelet Aggregation Inhibitors therapeutic use; Proton Pump Inhibitors therapeutic use","interest_area":["Gastroenterology"," Internal Medicine"," Infectious Disease & Vaccines"],"abstract":"The Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers were previously developed under co-work with the Korean College of Helicobacter and Upper Gastrointestinal Research and Korean Society of Gastroenterology at 2009. On the other hand, the previous guidelines were based mainly on a literature review and expert opinions. Therefore, the guidelines need to be revised. In this study, a guideline development committee for drug-induced peptic ulcers was organized under the Korean College of Helicobacter and Upper Gastrointestinal Research in 2017. Nine statements were developed, including four for NSAID, three for aspirin and other antiplatelet agents, and two for anticoagulants through de novo processes based on evidence-based medicine, such as a literature search, meta-analysis, and the consensus was established using the modified Delphi method. The primary target of this guideline was adult patients taking long-term NSAIDs, aspirin, or other antiplatelet agent and anticoagulants. The revised guidelines reflect the consensus of expert opinions and are intended to assist relevant clinicians in the management and prevention of drug-induced peptic ulcers and associated conditions.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=32969360&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Joo MK, Park CH, Kim JS, Park JM, Ahn JY, Lee BE, Lee JH, Yang HJ, Cho YK, Bang CS, Kim BJ, Jung HK, Kim BW, Lee YC","Corporate_Authors":"Korean College of Helicobacter and Upper Gastrointestinal Research","Journal_Info":"Publisher: Korean Society of Gastroenterology Country of Publication: Korea (South) NLM ID: 101189416 Publication Model: Print Cited Medium: Internet ISSN: 2233-6869 (Electronic) Linking ISSN: 15989992 NLM ISO Abbreviation: Korean J Gastroenterol Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline; Review","Published_Date":"2020-09-25","Source":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi [Korean J Gastroenterol] 2020 Sep 25; Vol. 76 (3), pp. 108-133.","Languages":"Korean","Electronic_ISSN":"2233-6869","MeSH_Terms":"Peptic Ulcer\/*prevention & control, Anti-Inflammatory Agents\/adverse effects ; Anti-Inflammatory Agents\/therapeutic use ; Anticoagulants\/adverse effects ; Anticoagulants\/therapeutic use ; Cyclooxygenase 2 Inhibitors\/therapeutic use ; Endoscopy, Gastrointestinal ; Helicobacter Infections\/diagnosis ; Helicobacter Infections\/drug therapy ; Hemorrhage\/complications ; Hemorrhage\/therapy ; Humans ; Peptic Ulcer\/diagnosis ; Peptic Ulcer\/etiology ; Platelet Aggregation Inhibitors\/adverse effects ; Platelet Aggregation Inhibitors\/therapeutic use ; Proton Pump Inhibitors\/therapeutic use","Subjects":"Anti-Inflammatory Agents adverse effects, Anti-Inflammatory Agents therapeutic use, Anticoagulants adverse effects, Anticoagulants therapeutic use, Cyclooxygenase 2 Inhibitors therapeutic use, Endoscopy, Gastrointestinal, Helicobacter Infections diagnosis, Helicobacter Infections drug therapy, Hemorrhage complications, Hemorrhage therapy, Humans, Peptic Ulcer diagnosis, Peptic Ulcer etiology, Platelet Aggregation Inhibitors adverse effects, Platelet Aggregation Inhibitors therapeutic use, Proton Pump Inhibitors therapeutic use, Peptic Ulcer prevention & control","Title_Abbreviations":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","Volume":"76"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"32969360","RelevancyScore":"872","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"872.463073730469"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=32969360&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=32969360&authtype=shib&custid=ns346513&group=main&profile=eds"}